GD-ZIPRASIDONE DIN 02441373
Status: Cancelled Pre Market
Holder: GENMED A DIVISION OF PFIZER CANADA ULC
Health Canada record
| Active ingredient(s) | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AE04 ZIPRASIDONE |
| Original market date | |
| Current status date | 13-Oct-2020 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02449544 | AURO-ZIPRASIDONE | AURO PHARMA INC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MG | Marketed |
| 02449579 | AURO-ZIPRASIDONE | AURO PHARMA INC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MG | Marketed |
| 02449560 | AURO-ZIPRASIDONE | AURO PHARMA INC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MG | Marketed |
| 02449552 | AURO-ZIPRASIDONE | AURO PHARMA INC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MG | Marketed |
| 02298600 | ZELDOX | BGP PHARMA ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MG | Marketed |
| 02298597 | ZELDOX | BGP PHARMA ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MG | Marketed |
| 02298619 | ZELDOX | BGP PHARMA ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MG | Marketed |
| 02298627 | ZELDOX | BGP PHARMA ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MG | Marketed |
| 02441365 | GD-ZIPRASIDONE | GENMED A DIVISION OF PFIZER CANADA ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MG | Cancelled Pre Market |
| 02441357 | GD-ZIPRASIDONE | GENMED A DIVISION OF PFIZER CANADA ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MG | Cancelled Pre Market |
| 02441381 | GD-ZIPRASIDONE | GENMED A DIVISION OF PFIZER CANADA ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MG | Cancelled Pre Market |
| 02429403 | MYLAN-ZIPRASIDONE | MYLAN PHARMACEUTICALS ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MG | Cancelled Pre Market |
| 02429381 | MYLAN-ZIPRASIDONE | MYLAN PHARMACEUTICALS ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MG | Cancelled Pre Market |
| 02429373 | MYLAN-ZIPRASIDONE | MYLAN PHARMACEUTICALS ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MG | Cancelled Pre Market |
| 02429365 | MYLAN-ZIPRASIDONE | MYLAN PHARMACEUTICALS ULC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MG | Cancelled Pre Market |
| 02478803 | PMS-ZIPRASIDONE | PHARMASCIENCE INC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MG | Cancelled Pre Market |
| 02478811 | PMS-ZIPRASIDONE | PHARMASCIENCE INC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MG | Cancelled Pre Market |
| 02478838 | PMS-ZIPRASIDONE | PHARMASCIENCE INC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MG | Cancelled Pre Market |
| 02478846 | PMS-ZIPRASIDONE | PHARMASCIENCE INC | Capsule | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 16990 | 2015-06-11 | New Drug Submission (NDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |